Is it appropriate to add bupropion (Wellbutrin) to a 30‑year‑old woman’s sertraline regimen to address sertraline‑induced decreased libido while remaining on the SSRI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adding Bupropion to Sertraline for SSRI-Induced Sexual Dysfunction

Yes, adding bupropion (Wellbutrin) to sertraline is appropriate and evidence-based for managing SSRI-induced decreased libido in this 30-year-old woman who needs to remain on her SSRI. 1, 2

Primary Recommendation

Bupropion augmentation is the first-line strategy when sexual dysfunction occurs with an SSRI and the patient must continue the SSRI for depression control. The American College of Physicians specifically recommends this approach, as bupropion has markedly lower sexual dysfunction rates (8-10%) compared to sertraline (14% ejaculatory failure, 6% decreased libido). 1, 2

Evidence Supporting Bupropion Augmentation

Efficacy Data

  • In a clinical trial of 47 patients with SSRI-induced sexual dysfunction, bupropion successfully reversed sexual complaints in 66% of patients (31/47), with 69% of individual sexual complaints improving. 3

  • Both as-needed dosing (75-150 mg taken 1-2 hours before sexual activity) and scheduled dosing (75 mg three times daily) were effective strategies. 3

  • Multiple controlled trials demonstrate that bupropion has significantly lower sexual dysfunction rates than sertraline, with one double-blind study showing 63% of men and 41% of women on sertraline developed sexual dysfunction versus only 15% of men and 7% of women on bupropion. 4, 5

Safety Profile

  • The combination of bupropion with SSRIs is generally well tolerated and safe, with open-label and controlled studies supporting this approach for both enhancing antidepressant response and reducing sexual side effects. 6

  • The main side effects leading to discontinuation are anxiety and tremor, occurring in approximately 15% of patients. 3

  • Bupropion carries a slightly increased seizure risk, so it should not be used in patients with seizure disorders or eating disorders. 2

Dosing Strategy

Initial Approach: As-Needed Dosing

  • Start with 75-150 mg bupropion taken 1-2 hours before anticipated sexual activity. 3

  • This strategy worked for 38% of patients in clinical trials and minimizes systemic exposure. 3

If As-Needed Dosing Fails: Scheduled Dosing

  • Gradually increase to 75 mg three times daily and sustain for 2 weeks. 3

  • If effective, continue this regimen long-term. 3

  • Maximum dose is 450 mg per day (typically using extended-release formulations for scheduled dosing). 7

Important Safety Considerations

Drug Interactions

  • Monitor for serotonin syndrome when combining bupropion with sertraline, though risk is lower than with other combinations. Watch for mental status changes, neuromuscular hyperactivity, and autonomic instability. 1

  • Be aware of potential cytochrome P450 interactions, as bupropion affects this enzyme system. 2

Contraindications

  • Do not use bupropion in patients with:
    • Current or prior seizure disorder 2
    • Current or prior eating disorder (anorexia/bulimia) 2
    • Significant agitation or anxiety 7
    • Abrupt discontinuation of alcohol or benzodiazepines 2

Alternative Considerations If Bupropion Fails or Is Contraindicated

Medication Alternatives

  • Switching from sertraline to bupropion monotherapy is the preferred alternative if augmentation fails, as approximately 62% of patients who switch antidepressants achieve treatment response. 1

  • Mirtazapine has lower sexual dysfunction rates than SSRIs but causes significant sedation and weight gain. 1

Non-Pharmacologic Adjuncts

  • Vibratory therapy can enhance orgasm intensity in patients with SSRI-related loss of genital sensation. 1

  • Pelvic floor physical therapy addresses co-existing pelvic dysfunction that may compound sexual problems. 1

  • Sex therapy or couples counseling helps patients develop adaptive strategies for managing SSRI-related sensory changes. 1

Monitoring Requirements

  • Assess response within 1-2 weeks of initiating bupropion, as most sexual adverse effects from SSRIs emerge early and improvements should be evident relatively quickly. 1

  • Modify treatment if no adequate response within 6-8 weeks of bupropion augmentation. 1

  • Directly inquire about sexual function at each visit, as patients rarely volunteer this information and clinical trial data substantially underreport the true prevalence of sexual dysfunction. 1

Critical Clinical Pearls

  • Sexual dysfunction from sertraline is dose-related, so consider reducing sertraline to the minimum effective dose before or concurrent with bupropion augmentation. 1

  • Ensure testosterone levels are normal (total morning testosterone >300 ng/dL in women), as low testosterone contributes to decreased libido independent of SSRI effects. 1

  • Screen for other medical contributors including diabetes, cardiovascular disease, and concomitant medications that impair sexual function. 1

  • If the patient were on tamoxifen for breast cancer, bupropion would still be preferred over continuing sertraline alone, though it has mild CYP2D6 inhibition effects. 1

References

Guideline

SSRI-Associated Sexual Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of SSRI-Induced Sexual Dysfunction with Bupropion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.